Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults.

Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, Landry ML. · 2010

Read Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. by Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, Landry ML. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2885414.txt.

Introduction

Sabetta and colleagues followed in 2010 whether blood vitamin D levels predict who catches viral respiratory infections. Vitamin D drops in fall and winter at northern latitudes, matching the cold and flu season, which hints at a link. They measured levels monthly in one hundred ninety-eight healthy adults through the 2009 to 2010 season, with assessors kept blind to the values.

Nearly everyone finished the study. Light skin, lean body mass, and taking supplements each tracked higher vitamin D levels. Adults who maintained levels at or above a fairly high threshold caught about half as many acute respiratory infections as those below it, and they lost fewer days to illness. The difference was stark and statistically strong, though the design cannot prove the vitamin itself deserves the credit.

Catalog record

CREATORSabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, Landry ML.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE41 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2885414

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Serum 25-Hydroxyvitamin D and the Incidence of Acute Viral Respiratory Tract Infections in Healthy Adults By James R Sabetta, Paolo DePetrillo, Ralph J Cipriani, Joanne Smardin, Lillian A Burns, Marie L Landry, Delia Goletti Published in: PLoS ONE DOI: 10.1371/journal.pone.0011088 ABSTRACT Abstract Background Declining serum concentrations of 25-hydroxyvitamin D seen in the fall and winter as distance increases from the equator may be a factor in the seasonal increased prevalence of influenza and other viral infections. This study was done to determine if serum 25-hydroxyvitamin D concentrations correlated with the incidence of acute viral respiratory tract infections. Methodology/Findings In this prospective cohort study serial monthly concentrations of 25-hydroxyvitamin D were measured over the fall and winter 2009–2010 in 198 healthy adults, blinded to the nature of the substance being measured. The participants were evaluated for the development of any acute respiratory tract infections by investigators blinded to the 25-hydroxyvitamin D concentrations. The incidence of infection in participants with different concentrations of vitamin D was determined. One hundred ninety-five (98.5%) of the enrolled participants completed the study. Light skin pigmentation, lean body mass, and supplementation with vitamin D were found to correlate with higher concentrations of 25-hydroxyvitamin D. Concentrations of 38 ng/ml or more were associated with a significant (p<0.0001) two-fold reduction in the risk of developing acute respiratory tract infections and with a marked reduction in the percentages of days ill. Conclusions/Significance Maintenance of a 25-hydroxyvitamin D serum concentration of 38 ng/ml or higher should significantly reduce the incidence of acute viral respiratory tract infections and the burden of illness caused thereby, at least during the fall and winter in temperate zones. The findings of the present study provide direction for and call for future interventional studies examining the efficacy of vitamin D supplementation in reducing the incidence and severity of specific viral infections, including influenza, in the general population and in subpopulations with lower 25-hydroxyvitamin D concentrations, such as pregnant women, dark skinned individuals, and the obese. INTRODUCTION There are seasonal variations in the incidences of viral respiratory tract infections, such as those caused by influenza [1], respiratory syncytial virus [2], and rhinovirus [3]. Explanations for the seasonality of infections have considered the effects of environmental factors on the survival and transmission of the pathogens [4], [5] as well as on the behavior and susceptibility of the hosts [6]. Indoor crowding is commonly thought to contribute to the influenza epidemics seen each winter in temperate zones. However, influenza epidemics do not occur in the summer in crowded workplaces or other gatherings, despite the presence of the virus and a multitude of nonimmune persons [6], [7]. Moreover, influenza epidemics occur simultaneously at the same latitudes across the globe; this was the case even in times when transportation methods did not allow contact between persons over many degrees of longitude over a period of a few weeks [8]. There are well-documented seasonal variations in 25-hydroxyvitamin D (vitamin D) concentrations [9]-[11] and documented correlations between those concentrations and latitudes of residence [12], [13]. Vitamin D has known effects on the immune system. The production of the antimicrobial peptides cathelicidin by macrophages and β-defensin by endothelial cells is upregulated by vitamin D [14], [15]. These peptides may be involved in the direct inactivation of viruses [16], [17]. Vitamin D may modulate the production of cytokines, suppressing inflammation [18], and, thereby, reduce the severity of viral pneumonia [19]. The association between vitamin D deficiency and susceptibility to infections of the respiratory tract has been suggested for many years, but has not been definitively proven. Children with nutritional rickets developed rachitic lung due to infections of the respiratory tract [20], [21]. Cod liver oil, rich in vitamin D, was used to treat tuberculosis [22]. Epidemiologic studies have suggested a correlation between vitamin D concentrations and the incidence of respiratory infections [23], [24], including influenza [25]. There have been no prospective, observational studies following adult women and men with known vitamin D concentrations for the development of acute viral respiratory tract infections. Since it is unknown if an acute infection could transiently alter the 25-hydroxyvitamin D concentration and concentrations would be expected to decline over the fall and winter as latitude increases from the equator, serial serum concentrations would have to be obtained in a prospective study done in a temperate zone. This study was undertaken to determine if there is any correlation between the incidence of acute viral respiratory tract infections and serum vitamin D concentrations as measured monthly from September 20, 2009 to January 10, 2010 in healthy adults living and/or working in or near Greenwich, CT, USA (latitude 41.038N, longitude 73.614W). METHODS Participants All participants signed informed consent approved by the Greenwich Hospital Institutional Review Board. Healthy adults, contacted through formal and informal presentations, were asked to volunteer to participate in this study. Exclusion criteria were any chronic pulmonary, cardiac, renal, hepatic, hematologic, neurologic, neuromuscular, or metabolic disorders (including diabetes mellitus); immunosuppression; pregnancy; and/or high dose aspirin therapy. Participants were not excluded if on thyroid or estrogen replacement therapy, oral contraceptives, or if they had mild seasonal allergies. Participants agreed to donate one tube (7.5 cc) of blood monthly, starting in the third week of September 2009, for 4–5 months, depending on an interim analysis after the third blood draw. The participants were unaware of the nature of the substance being measured; they also understood they would be told the substance and their concentrations at the end of the study and that this data might be of benefit to them for health reasons unrelated to the study. The participants were asked to report any evidence of an acute respiratory tract infection (rhinorrhea, sore throat, and/or cough with or without fever, chills, myalgias, arthralgias), in which case they would be evaluated without charge at the study site. Determination of 25-hydroxyvitamin D concentrations After obtained, sera were refrigerated and assayed within 4–48 hours in the Clinical Laboratory of Greenwich Hospital. Concentrations of 25-hydroxyvitamin D were measured in duplicate by a chemiluminescence immunoassay (Liaison®) [26]. The first concentrations were drawn from September 20–28, 2009, and then monthly thereafter. The investigators on site were blinded to the coded results, which were sent to the offsite investigator (PDP) who was not involved in clinical assessment. Clinical evaluation Participants reporting any symptoms were seen the same day at the study site by one of the two board-certified Infectious Diseases investigators (JRS, RJC). Participants were interviewed, examined, and, if felt to have an acute respiratory tract infection, had a nasopharyngeal swab obtained for virology studies and bacterial cultures if a bacterial infection was suspected. The participants kept a diary of symptoms and were called every 1–3 days during the illness to review any signs or symptoms until asymptomatic. The duration of each symptom, the total illness duration, and any antimicrobials administered were recorded in the case report forms. Between each monthly visit for 25-hydroxyvitamin D determinations, all of the participants were reminded every 10 days to report any illness. At each visit after the first, a clinical assessment was made by both of the Infectious Diseases investigators to determine if an illness being retrospectively reported by a participant appeared to have been an acute viral respiratory tract infection. In that

Read the complete text